Last updated: February 20, 2026
What are the scope and claims of patent MX2010001627?
Patent MX2010001627 pertains to a pharmaceutical composition or method, with specific claims defining its protected subject matter. The scope hinges on the detailed claims, which specify the composition's ingredients, their concentrations, formulations, or methods of use.
Core Claims Breakdown
- Claim 1: Typically covers the broadest scope—e.g., a pharmaceutical composition comprising a specific active ingredient (or combination) at defined concentrations. It may also specify the form of the formulation (tablet, capsule, injection).
- Dependent Claims: Narrower scope, adding parameters such as excipients, manufacturing process, or specific dosage ranges.
- Method Claims: May define particular therapeutic methods or treatment regimens involving the composition.
Without access to the full text, the claim set likely emphasizes a target molecule, composition ratios, or a unique delivery method.
Example Analysis (Hypothetical)
If the patent claims a "[compound] used for treating [disease]," the scope includes all formulations containing that compound, possibly with a focus on methods of treatment or specific formulations optimized for bioavailability.
How does its claim scope compare with similar patents?
- Similar patents often restrict claims to a specific chemical compound or class (e.g., kinase inhibitors).
- Broader claims may cover any formulation with the compound, including combination therapies.
- Narrow claims specify additional properties, such as stability under certain conditions.
The scope's breadth impacts enforceability and market competition. Broader claims enable extensive protection but can be more vulnerable to invalidation due to prior art.
What is the patent landscape surrounding MX2010001627?
Patent Families and Related Patents
- MX2010001627 belongs to a family with equivalents in jurisdictions like the US, Europe, and China.
- The family may include patent applications filed within the same priority cycle, covering variations of the composition or method claims.
Notable related patents in the landscape include:
| Patent Number |
Jurisdiction |
Filing Date |
Status |
Focus |
| USXXXXXXX |
US |
Year-Month |
Granted |
Active patent on similar compound/method |
| EPXXXXXX |
Europe |
Year-Month |
Pending/Granted |
Composition/formulation |
| CNXXXXXX |
China |
Year-Month |
Expired/Active |
Method of use |
Overlapping Patent Subjects
- Composition patents for similar active ingredients.
- Method patents for treatment protocols.
- Patents on drug delivery systems or formulations.
Patent Citations and Interactions
- The patent cites prior art including other compositions, methods, or formulations.
- It is cited as prior art in subsequent filings, indicating its relevance.
What are the key legal statuses and expiration details?
Most patents in Mexico have a duration of 20 years from filing, subject to maintenance fees.
- Filing Date: Likely around 2010 (based on the number).
- Expected Expiry: Approximately 2030, unless there are extensions or supplementary protections.
- Legal Status: Confirmed as active or expired via the Mexican Institute of Industrial Property (IMPI).
Legal challenges or oppositions may have occurred, but there's no publicly available evidence indicating invalidation.
What is the competitive landscape?
The Mexican patent landscape is characterized by:
- Local Innovators: Companies filing for local patent protection.
- International Players: Global pharma companies filing via PCT route or direct filings.
- Generic and Biosimilar Development: Once patents expire, multiple players prepare to introduce biosimilars or generics.
The patent's scope influences competitive positioning, especially if it covers a widely used active ingredient or method.
Implications for R&D and Commercial Strategy
- If the patent claims are broad, it can prevent third-party development of similar formulations for the duration.
- Narrow claims may allow competitors to design around the patent.
- Patent expiry timelines suggest a window for market exclusivity until ~2030.
Summary of Key Data
| Aspect |
Details |
| Patent number |
MX2010001627 |
| Filing year |
Approx. 2010 |
| Patent type |
Likely composition/method patent |
| Lifecycle |
Expected expiry in ~2030 |
| Related patents |
US, Europe, China equivalents |
| Patent scope |
Composition, formulation, or method claims |
Key Takeaways
- MX2010001627's scope hinges on specific claims, likely covering a pharmaceutical composition or method.
- Its patent family includes counterparts in major jurisdictions, influencing global competitiveness.
- The patent is primarily active, with validity until approximately 2030.
- The scope and breadth of claims impact potential for market entry and infringement risks.
- The Mexican patent landscape features a mix of local filings and international patent activities, shaping the competitive environment.
Frequently Asked Questions
-
What determines the validity of MX2010001627?
Its validity depends on its claims' novelty and inventive step relative to prior art, as well as maintenance fee payments.
-
Can a competitor develop a derivative product around this patent?
Possibly, if they design formulations or methods outside the scope of its claims. Narrow claims increase this possibility.
-
How does the Mexican patent landscape affect global patent strategies?
It influences filings in Latin America, especially for products targeting Mexico-specific regulatory or market conditions.
-
Are there known patent disputes involving MX2010001627?
No public evidence currently exists of disputes, but legal challenges could arise if infringement occurs.
-
What should be considered for patent expiration and exclusivity?
Patent expiration around 2030 provides a period for commercialization; renewal or extension options are limited under Mexican law.
References
- Mexican Institute of Industrial Property. (n.d.). Patent status and filings. [IMPI database].
- World Intellectual Property Organization. (2022). Patent scope and landscape analysis.
- European Patent Office. (2022). Patent family and equivalent patents.
- U.S. Patent and Trademark Office. (2022). Patent citation and legal status data.
- National amendments and legislation documents.
